Stocks and Investing Stocks and Investing
Wed, September 4, 2024
Tue, September 3, 2024
Fri, August 30, 2024

Serge Belanger Reiterated (VRDN) at Strong Buy and Held Target at $30 on, Aug 30th, 2024


Published on 2024-10-28 13:59:41 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $30 on, Aug 30th, 2024.

Serge has made no other calls on VRDN in the last 4 months.



There are 8 other peers that have a rating on VRDN. Out of the 8 peers that are also analyzing VRDN, 2 agree with Serge's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Michael Higgins of "Ladenburg Thalmann" Downgraded from Strong Buy to Hold on, Thursday, May 9th, 2024
  • Kalpit Patel of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $20 on, Thursday, May 9th, 2024


These are the ratings of the 6 analyists that currently disagree with Serge


  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Wednesday, August 28th, 2024
  • Douglas Tsao of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $27 on, Thursday, August 15th, 2024
  • Leland Gershell of "Oppenheimer" Reiterated at Buy with Decreased Target to $28 on, Monday, August 12th, 2024
  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $42 on, Monday, July 29th, 2024
  • Andy Chen of "Wolfe Research" Initiated at Buy on, Tuesday, June 11th, 2024
  • Richard Law of "Goldman Sachs" Initiated at Strong Buy and Held Target at $23 on, Thursday, June 6th, 2024